1082 related articles for article (PubMed ID: 17628686)
1. Predictors of long-term progression in the early manifest glaucoma trial.
Leske MC; Heijl A; Hyman L; Bengtsson B; Dong L; Yang Z;
Ophthalmology; 2007 Nov; 114(11):1965-72. PubMed ID: 17628686
[TBL] [Abstract][Full Text] [Related]
2. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial.
Bengtsson B; Leske MC; Hyman L; Heijl A;
Ophthalmology; 2007 Feb; 114(2):205-9. PubMed ID: 17097736
[TBL] [Abstract][Full Text] [Related]
3. Disc hemorrhages and treatment in the early manifest glaucoma trial.
Bengtsson B; Leske MC; Yang Z; Heijl A;
Ophthalmology; 2008 Nov; 115(11):2044-8. PubMed ID: 18692244
[TBL] [Abstract][Full Text] [Related]
4. Intraocular pressure reduction with a fixed treatment protocol in the Early Manifest Glaucoma Trial.
Heijl A; Leske MC; Hyman L; Yang Z; Bengtsson B;
Acta Ophthalmol; 2011 Dec; 89(8):749-54. PubMed ID: 20236252
[TBL] [Abstract][Full Text] [Related]
5. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial.
Leske MC; Heijl A; Hussein M; Bengtsson B; Hyman L; Komaroff E;
Arch Ophthalmol; 2003 Jan; 121(1):48-56. PubMed ID: 12523884
[TBL] [Abstract][Full Text] [Related]
6. Intercurrent factors associated with the development of open-angle glaucoma in the European glaucoma prevention study.
Miglior S; Torri V; Zeyen T; Pfeiffer N; Vaz JC; Adamsons I;
Am J Ophthalmol; 2007 Aug; 144(2):266-275. PubMed ID: 17543874
[TBL] [Abstract][Full Text] [Related]
7. Treatment and vision-related quality of life in the early manifest glaucoma trial.
Hyman LG; Komaroff E; Heijl A; Bengtsson B; Leske MC;
Ophthalmology; 2005 Sep; 112(9):1505-13. PubMed ID: 16019074
[TBL] [Abstract][Full Text] [Related]
8. Silent cerebral infarct and visual field progression in newly diagnosed normal-tension glaucoma: a cohort study.
Leung DY; Tham CC; Li FC; Kwong YY; Chi SC; Lam DS
Ophthalmology; 2009 Jul; 116(7):1250-6. PubMed ID: 19481813
[TBL] [Abstract][Full Text] [Related]
9. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study.
Caprioli J; Coleman AL
Ophthalmology; 2008 Jul; 115(7):1123-1129.e3. PubMed ID: 18082889
[TBL] [Abstract][Full Text] [Related]
10. Trabeculectomy with mitomycin C: outcomes and risk factors for failure in phakic open-angle glaucoma.
Fontana H; Nouri-Mahdavi K; Lumba J; Ralli M; Caprioli J
Ophthalmology; 2006 Jun; 113(6):930-6. PubMed ID: 16647135
[TBL] [Abstract][Full Text] [Related]
11. Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study.
; Miglior S; Pfeiffer N; Torri V; Zeyen T; Cunha-Vaz J; Adamsons I
Ophthalmology; 2007 Jan; 114(1):3-9. PubMed ID: 17070596
[TBL] [Abstract][Full Text] [Related]
12. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study.
Nouri-Mahdavi K; Hoffman D; Coleman AL; Liu G; Li G; Gaasterland D; Caprioli J;
Ophthalmology; 2004 Sep; 111(9):1627-35. PubMed ID: 15350314
[TBL] [Abstract][Full Text] [Related]
13. Factors affecting rates of visual field progression in glaucoma patients with optic disc hemorrhage.
Prata TS; De Moraes CG; Teng CC; Tello C; Ritch R; Liebmann JM
Ophthalmology; 2010 Jan; 117(1):24-9. PubMed ID: 19896197
[TBL] [Abstract][Full Text] [Related]
14. Optic disc and visual field changes after trabeculectomy.
Kotecha A; Spratt A; Bunce C; Garway-Heath DF; Khaw PT; Viswanathan A;
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4693-9. PubMed ID: 19474409
[TBL] [Abstract][Full Text] [Related]
15. Incorporating corneal pachymetry into the management of glaucoma.
Iester M; Mete M; Figus M; Frezzotti P
J Cataract Refract Surg; 2009 Sep; 35(9):1623-8. PubMed ID: 19683164
[TBL] [Abstract][Full Text] [Related]
16. Predictors for visual field progression and the effects of treatment with dorzolamide 2% or brinzolamide 1% each added to timolol 0.5% in primary open-angle glaucoma.
Martínez A; Sanchez-Salorio M
Acta Ophthalmol; 2010 Aug; 88(5):541-52. PubMed ID: 19799592
[TBL] [Abstract][Full Text] [Related]
17. The singapore 5-Fluorouracil trabeculectomy study: effects on intraocular pressure control and disease progression at 3 years.
Wong TT; Khaw PT; Aung T; Foster PJ; Htoon HM; Oen FT; Gazzard G; Husain R; Devereux JG; Minassian D; Tan SB; Chew PT; Seah SK
Ophthalmology; 2009 Feb; 116(2):175-84. PubMed ID: 19187822
[TBL] [Abstract][Full Text] [Related]
18. Effects of argon laser trabeculoplasty in the Early Manifest Glaucoma Trial.
Heijl A; Peters D; Leske MC; Bengtsson B
Am J Ophthalmol; 2011 Nov; 152(5):842-8. PubMed ID: 21843876
[TBL] [Abstract][Full Text] [Related]
19. Beta-Zone parapapillary atrophy and the velocity of glaucoma progression.
Teng CC; De Moraes CG; Prata TS; Tello C; Ritch R; Liebmann JM
Ophthalmology; 2010 May; 117(5):909-15. PubMed ID: 20132988
[TBL] [Abstract][Full Text] [Related]
20. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
Martínez A; Sánchez M
Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
